Honeywell Aerospace Supply Chain Disrupted, Full-Year Growth Guidance Cut to 4%-5%
0xBroomberg
Honeywell Aerospace slashed its full-year organic sales growth forecast from up to 9% down to 4%–5%, while its first-ever EPS guidance came in well below Wall Street expectations — a rough debut for a company barely a month into life as an independent.
Growth guidance nearly halved — what happened?
The company cut full-year organic sales growth from a prior high of 9% to 4%–5%, nearly halving the target.
The culprit: supply constraints on specific components, with a subset of suppliers ramping capacity slower than expected in Q2.
CEO Jim Currier called it "prudent" to align guidance with supply-chain "actual capacity." This means → management is conceding it cannot fix the bottleneck on its own and is resetting the market's bar instead.
Why did the earnings guide disappoint Wall Street?
Honeywell Aerospace issued its first full-year adjusted EPS guidance at $7.60–$7.90.
Analysts had been expecting $8.68 — the company's range sits roughly 10%–12% below consensus.
In plain terms = Wall Street expected a freshly independent company to come out swinging; instead, the first scorecard said "we can't hit the number you had in mind."
Why is Honeywell Aerospace falling behind its peers?
Aerospace supply-chain bottlenecks have plagued the industry since the pandemic, but other majors have recently shown improvement.
GE Aerospace CEO Larry Culp said in July that the company is seeing key supplier deliveries improving.
This reflects an uneven distribution of supply-chain pain across the sector — on the same runway, some players are accelerating while others are still stuck in traffic.
What comes next?
The cut arrives barely one month after Honeywell Aerospace spun off from parent Honeywell — marking the new company's first major setback in the public market.
Whether suppliers can restore capacity in the second half will directly determine if the 4%–5% revised guidance holds.
This means → if the supply chain stays jammed through H2, even this already-lowered target carries downside risk.
Content is for reference only, not financial advice.